29 related articles for article (PubMed ID: 8678493)
1. Quality of life assessment and reporting in randomized controlled trials: a study of literature published from Japan.
Naito M; Nakayama T; Fukuhara S
Health Qual Life Outcomes; 2004 Jun; 2():31. PubMed ID: 15217517
[TBL] [Abstract][Full Text] [Related]
2. Quality of life in patients with skeletal metastases of prostate cancer and status prior to start of endocrine therapy: results from the Scandinavian Prostate Cancer Group Study 5.
Jønler M; Nielsen OS; Groenvold M; Hedlund PO; Damber L; Hedelin H; Waldén M;
Scand J Urol Nephrol; 2005; 39(1):42-8. PubMed ID: 15764270
[TBL] [Abstract][Full Text] [Related]
3. Intermittent androgen suppression for locally advanced and metastatic prostate cancer: preliminary report of a prospective multicenter study.
Sato N; Akakura K; Isaka S; Nakatsu H; Tanaka M; Ito H; Masai M;
Urology; 2004 Aug; 64(2):341-5. PubMed ID: 15302491
[TBL] [Abstract][Full Text] [Related]
4. Gynecomastia and breast pain induced by adjuvant therapy with bicalutamide after radical prostatectomy in patients with prostate cancer: the role of tamoxifen and radiotherapy.
Di Lorenzo G; Perdonà S; De Placido S; D'Armiento M; Gallo A; Damiano R; Pingitore D; Gallo L; De Sio M; Autorino R
J Urol; 2005 Dec; 174(6):2197-203. PubMed ID: 16280763
[TBL] [Abstract][Full Text] [Related]
5. Quality of life impact of three different doses of suramin in patients with metastatic hormone-refractory prostate carcinoma: results of Intergroup O159/Cancer and Leukemia Group B 9480.
Ahles TA; Herndon JE; Small EJ; Vogelzang NJ; Kornblith AB; Ratain MJ; Stadler W; Palchak D; Marshall ME; Wilding G; Petrylak D; Holland JC;
Cancer; 2004 Nov; 101(10):2202-8. PubMed ID: 15484217
[TBL] [Abstract][Full Text] [Related]
6. [QOL assessment in the treatment of prostate cancer].
Isaka S
Gan To Kagaku Ryoho; 1996 Mar; 23(4):427-31. PubMed ID: 8678493
[TBL] [Abstract][Full Text] [Related]
7. Health-related quality of life, satisfaction, and economic outcome measures in studies of prostate cancer screening and treatment, 1990-2000.
McNaughton-Collins M; Walker-Corkery E; Barry MJ
J Natl Cancer Inst Monogr; 2004; (33):78-101. PubMed ID: 15504921
[TBL] [Abstract][Full Text] [Related]
8. External beam radiotherapy in bone metastatic prostate cancer: impact on patients' pain relief and quality of life.
Di Lorenzo G; Autorino R; Ciardiello F; Raben D; Bianco C; Troiani T; Pizza C; De Laurentiis M; Pensabene M; D'Armiento M; Bianco AR; De Placido S
Oncol Rep; 2003; 10(2):399-404. PubMed ID: 12579279
[TBL] [Abstract][Full Text] [Related]
9. Global update on defining and treating high-risk localized prostate cancer with leuprorelin: an Asian perspective.
Mizokami A; Ueno S; Fukagai T; Ito K; Ehara H; Kinbara H; Origasa H; Usami M; Namiki M; Akaza H
BJU Int; 2007 Jan; 99 Suppl 1():6-9; discussion 17-8. PubMed ID: 17229160
[TBL] [Abstract][Full Text] [Related]
10. [An overview of clinical trials in endocrine therapy for cancer].
Hinotsu S; Ohasi Y; Akaza H
Gan To Kagaku Ryoho; 1996 May; 23(6):689-94. PubMed ID: 8645019
[TBL] [Abstract][Full Text] [Related]
11. Radiotherapy combined with hormonal therapy (RT-HT) in prostate cancer patients with low, intermediate, and high risk of biochemical recurrence: perspective and therapeutic gain analysis.
Milecki P; Kwias Z; Martenka DJ
Neoplasma; 2007; 54(1):7-15. PubMed ID: 17203887
[TBL] [Abstract][Full Text] [Related]
12.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
13.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
14.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
15.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
16.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
17.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
18.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
19.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]